Biochemical indicator | No. of studies | No. of ALS/controls* | Main effect | Heterogeneity | Â | Publication bias | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
WMD | Lower 95%CI | High 95% CI | z score | p value | df | p value | I2 statistic | Egger intercept | p value | |||
Total cholesterol | 17 | 2801/4545 | 4.44 | −2.62 | 11.50 | 1.23 | 0.22 | 21 | < 0.001 | 89.40% | 1.42 | 0.23 |
LDL-C | 13 | 2677/4347 | 0.46 | −6.56 | 7.47 | 0.13 | 0.90 | 16 | < 0.001 | 95.10% | 0.24 | 0.88 |
HDL-C | 14 | 2707/4376 | 1.67 | −0.89 | 4.24 | 1.28 | 0.20 | 17 | < 0.001 | 86.70% | 2.57 | 0.02 |
TG | 11 | 2366/2261 | 0.11 | −9.15 | 9.37 | 0.02 | 0.98 | 12 | < 0.001 | 83.90% | −2.13 | 0.05 |
Fasting blood glucose | 9 | 301/241 | 0.13 | 0.06 | 0.21 | 3.38 | 0.001 | 9 | 0.39 | 5.60% | 0.51 | 0.35 |
Fasting insulin | 6 | 94/88 | −6.79 | −29.27 | 15.70 | 0.59 | 0.55 | 6 | < 0.001 | 89.70% | 2.19 | 0.59 |
CSF glucose | 3 | 132/91 | 0.04 | −0.10 | 0.18 | 0.54 | 0.59 | 2 | 0.18 | 41.50% | 1.91 | 0.56 |
CSF total protein | 6 | 417/165 | −1.53 | −5.19 | 2.12 | 1.31 | 0.19 | 4 | 0.64 | 0.00% | −0.11 | 0.89 |
Qalb | 7 | 627/212 | 0.44 | −0.51 | 1.39 | 0.91 | 0.36 | 6 | 0.001 | 72.20% | −0.47 | 0.72 |
Serum albumin | 3 | 630/611 | −1.52 | −5.53 | 2.48 | 0.74 | 0.46 | 2 | < 0.001 | 94.80% | 5.37 | 0.002 |
Serum total protein | 3 | 705/690 | −0.44 | −1.03 | 0.14 | 1.49 | 0.14 | 2 | < 0.001 | 98.80% | 15.64 | 0.25 |
Serum ferritin | 9 | 1661/1219 | 63.42 | 48.12 | 78.73 | 8.12 | < 0.001 | 15 | 0.001 | 67.60% | 1.89 | 0.06 |
Serum transferrin | 7 | 1163/718 | 0.07 | −0.58 | 0.72 | 0.21 | 0.83 | 10 | < 0.001 | 99.60% | −0.41 | 0.96 |
Serum iron | 6 | 974/659 | 0.34 | −0.68 | 1.36 | 0.66 | 0.51 | 7 | 0.012 | 61.10% | −2.18 | 0.15 |
TIBC | 3 | 236/304 | −2.42 | −3.93 | −0.90 | 3.12 | 0.002 | 3 | 0.29 | 19.60% | 0.05 | 0.99 |
TSC % | 3 | 858/486 | 2.79 | 1.52 | 4.05 | 4.33 | < 0.001 | 3 | 0.96 | 0 | 1.02 | 0.35 |
Creatine kinase | 5 | 229/1843 | 80.29 | 32.90 | 127.67 | 3.32 | 0.001 | 6 | < 0.001 | 93.20% | 5.51 | 0.27 |